177 related articles for article (PubMed ID: 28277612)
1. WDR62 overexpression is associated with a poor prognosis in patients with lung adenocarcinoma.
Shinmura K; Kato H; Kawanishi Y; Igarashi H; Inoue Y; Yoshimura K; Nakamura S; Fujita H; Funai K; Tanahashi M; Niwa H; Ogawa H; Sugimura H
Mol Carcinog; 2017 Aug; 56(8):1984-1991. PubMed ID: 28277612
[TBL] [Abstract][Full Text] [Related]
2. CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients.
Shi R; Zhang C; Wu Y; Wang X; Sun Q; Sun J; Xia W; Dong G; Wang A; Jiang F; Xu L
Oncotarget; 2017 Mar; 8(12):19768-19779. PubMed ID: 28423619
[TBL] [Abstract][Full Text] [Related]
3. Elevated mRNA Levels of AURKA, CDC20 and TPX2 are associated with poor prognosis of smoking related lung adenocarcinoma using bioinformatics analysis.
Zhang MY; Liu XX; Li H; Li R; Liu X; Qu YQ
Int J Med Sci; 2018; 15(14):1676-1685. PubMed ID: 30588191
[No Abstract] [Full Text] [Related]
4. MAGE-A family expression is correlated with poor survival of patients with lung adenocarcinoma: a retrospective clinical study based on tissue microarray.
Sang M; Gu L; Yin D; Liu F; Lian Y; Zhang X; Liu S; Huang W; Wu Y; Shan B
J Clin Pathol; 2017 Jun; 70(6):533-540. PubMed ID: 27864450
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation mediated silencing of microRNA-145 is a potential prognostic marker in patients with lung adenocarcinoma.
Xia W; Chen Q; Wang J; Mao Q; Dong G; Shi R; Zheng Y; Xu L; Jiang F
Sci Rep; 2015 Nov; 5():16901. PubMed ID: 26582602
[TBL] [Abstract][Full Text] [Related]
6. LAPTM4B is a novel diagnostic and prognostic marker for lung adenocarcinoma and associated with mutant EGFR.
Wang L; Meng Y; Zhang QY
BMC Cancer; 2019 Apr; 19(1):293. PubMed ID: 30940109
[TBL] [Abstract][Full Text] [Related]
7. High Expression of Krüppel-like Factor 7 Indicates Unfavorable Clinical Outcomes in Patients with Lung Adenocarcinoma.
Niu R; Tang Y; Xi Y; Jiang D
J Surg Res; 2020 Jun; 250():216-223. PubMed ID: 32092599
[TBL] [Abstract][Full Text] [Related]
8. Keratin 17 Promotes Lung Adenocarcinoma Progression by Enhancing Cell Proliferation and Invasion.
Liu J; Liu L; Cao L; Wen Q
Med Sci Monit; 2018 Jul; 24():4782-4790. PubMed ID: 29991674
[TBL] [Abstract][Full Text] [Related]
9. Elevated MACC1 expression predicts poor prognosis in small invasive lung adenocarcinoma.
Guo T; Zhao S; Li Z; Li F; Li J; Gu C
Cancer Biomark; 2018; 22(2):301-310. PubMed ID: 29630522
[TBL] [Abstract][Full Text] [Related]
10. WD40 repeat-containing 62 overexpression as a novel indicator of poor prognosis for human gastric cancer.
Zeng S; Tao Y; Huang J; Zhang S; Shen L; Yang H; Pei H; Zhong M; Zhang G; Liu T; Zhou M; Shen H
Eur J Cancer; 2013 Nov; 49(17):3752-62. PubMed ID: 23920402
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of atypical protein kinase C (PKCι and PKCζ) and its relationship with yes-associated protein in lung adenocarcinoma.
Kim KH; Chung C; Kim JM; Lee D; Cho SY; Lee TH; Cho HJ; Yeo MK
BMC Cancer; 2019 Aug; 19(1):804. PubMed ID: 31412817
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.
He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D
Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781
[TBL] [Abstract][Full Text] [Related]
13. Increased stathmin correlates with advanced stage and poor survival of non-small cell lung cancer.
Rong B; Nan Y; Liu H; Gao W
Cancer Biomark; 2017; 19(1):35-43. PubMed ID: 28282798
[TBL] [Abstract][Full Text] [Related]
14. MARCH9 Suppresses Lung Adenocarcinoma Progression by Downregulating ICAM-1.
Shen QM; Wang HY; Xu S
Cell Physiol Biochem; 2018; 50(1):92-107. PubMed ID: 30278450
[TBL] [Abstract][Full Text] [Related]
15. Role of HOXB7 in regulation of progression and metastasis of human lung adenocarcinoma.
Yuan W; Zhang X; Xu Y; Li S; Hu Y; Wu S
Mol Carcinog; 2014 Jan; 53(1):49-57. PubMed ID: 22911672
[TBL] [Abstract][Full Text] [Related]
16. The Overexpression of FEN1 and RAD54B May Act as Independent Prognostic Factors of Lung Adenocarcinoma.
Hwang JC; Sung WW; Tu HP; Hsieh KC; Yeh CM; Chen CJ; Tai HC; Hsu CT; Shieh GS; Chang JG; Yeh KT; Liu TC
PLoS One; 2015; 10(10):e0139435. PubMed ID: 26431531
[TBL] [Abstract][Full Text] [Related]
17. NCAPG2 promotes tumour proliferation by regulating G2/M phase and associates with poor prognosis in lung adenocarcinoma.
Zhan P; Xi GM; Zhang B; Wu Y; Liu HB; Liu YF; Xu WJ; Zhu Q; Cai F; Zhou ZJ; Miu YY; Wang XX; Jin JJ; Li Q; Lv TF; Song Y
J Cell Mol Med; 2017 Apr; 21(4):665-676. PubMed ID: 27862966
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of CRKL correlates with poor prognosis and cell proliferation in non-small cell lung cancer.
Wang Y; Dong QZ; Fu L; Stoecker M; Wang E; Wang EH
Mol Carcinog; 2013 Nov; 52(11):890-9. PubMed ID: 22753141
[TBL] [Abstract][Full Text] [Related]
19. High expression of transcriptional factor HoxB9 predicts poor prognosis in patients with lung adenocarcinoma.
Zhan J; Wang P; Niu M; Wang Y; Zhu X; Guo Y; Zhang H
Histopathology; 2015 Jun; 66(7):955-65. PubMed ID: 25324169
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
